THEMIS MEDICARE
Back to Balance Sheet
|
THEMIS MEDICARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹8.83 Cr | ₹7.39 Cr | ₹6.94 Cr | ₹6.47 Cr | ₹0.95 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of THEMIS MEDICARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹8.83 Cr |
| Mar2024 | ₹7.39 Cr |
| Mar2023 | ₹6.94 Cr |
| Mar2022 | ₹6.47 Cr |
| Mar2021 | ₹0.95 Cr |
How is Deferred Tax Assets / Liabilities of THEMIS MEDICARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.83 Cr | 19.45 | |
| Mar2024 | ₹7.39 Cr | 6.51 | |
| Mar2023 | ₹6.94 Cr | 7.25 | |
| Mar2022 | ₹6.47 Cr | 582.70 | |
| Mar2021 | ₹0.95 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹794.8 Cr | -3% | 7.2% | -50.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | -3% |
7.2% |
-50.3% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses